metoclopramide
Selected indexed studies
- Metoclopramide for the treatment of diabetic gastroparesis. (Expert Rev Gastroenterol Hepatol, 2019) [PMID:31314613]
- Metoclopramide--a review. (Med J Aust, 1986) [PMID:3515136]
- Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited. (Neurogastroenterol Motil, 2019) [PMID:31050085]
_Worker-drafted node — pending editorial review._
Connections
metoclopramide is a side effect of
Sources
- Metoclopramide for the treatment of diabetic gastroparesis. (2019) pubmed
- Metoclopramide--a review. (1986) pubmed
- Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited. (2019) pubmed
- Metoclopramide nasal spray (Gimoti) for diabetic gastroparesis. (2021) pubmed
- Intranasal metoclopramide. (1999) pubmed
- Metoclopramide. (1983) pubmed
- Drug therapy. Metoclopramide. (1981) pubmed
- Beyond Metoclopramide for Gastroparesis. (2022) pubmed
- Metoclopramide nasal spray for management of symptoms of acute and recurrent diabetic gastroparesis in adults. (2021) pubmed
- Metoclopramide: pharmacology and clinical application. (1983) pubmed